Pericardial Tuberculosis
ICD-10 A18.8 · ICD-11 1B12.0

Treatment of Pericardial Tuberculosis Presenting as Constrictive Pericarditis

Tuberculous pericarditis can manifest in distinct forms. When constrictive pericarditis is the predominant presentation, the clinical and therapeutic considerations differ from other forms of the disease, and the choice of initial approach carries particular importance.

Clinical Scenario

Tuberculous pericarditis presents clinically in three forms: pericardial effusion, constrictive pericarditis, and a combination of effusion and constriction. This protocol specifically addresses the scenario where constrictive pericarditis is the defining feature of presentation.

Treatment Goal

The primary therapeutic aim is resolution of pericardial constriction on antituberculosis chemotherapy within six months of initiating treatment.

Approach Overview (Partial)

Management of tuberculous pericardial constriction centres on antituberculosis drug therapy. For noncalcific pericardial constriction, a trial of medical therapy is a recommended initial step before considering surgical intervention. The complete regimen — including specific agents, treatment sequence, duration, and criteria for escalation — is available in the full protocol.

Full regimen, sequencing, and decision algorithm available below →

Instant Access to Structured Evidence-Based Regimens

References

  1. Tuberculous pericarditis presents clinically in 3 forms, namely, pericardial effusion, constrictive pericarditis, and a combination of effusion and constriction.
  2. The treatment of tuberculous pericardial constriction involves the use of standard antituberculosis drugs for 6 months and pericardiectomy for persistent constriction in the face of drug therapy.
  3. The timing of surgical intervention is controversial, but many experts recommend a trial of medical therapy for noncalcific pericardial constriction, and pericardiectomy in nonresponders after 4 to 8 weeks of antituberculosis chemotherapy.
  4. The remarkable finding of this study is that constriction resolved on antituberculosis chemotherapy within 6 months in most patients, and only 29 (25%) of the 114 patients required pericardiectomy for persistent or worsening constriction during the follow-up of 2 years.
DOI: 10.1161/circulationaha.105.543066 View source ↗